Interestingly, we and others previously noticed an increased sensitivity of MYCN-dependent neuroblastoma towards mTOR inhibition27,36, suggesting that simultaneous blockade of glycolysis and mTOR would be an option to interfere with both, metabolism and survival pathways. The gene discussed is MTOR; the disease is neuroblastoma.